Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Journal of Pediatric Endocrinology and Metabolism

Editor-in-Chief: Kiess, Wieland

Ed. by Bereket, Abdullah / Darendeliler, Feyza / Dattani, Mehul / Gustafsson, Jan / Luo, Fei Hong / Toppari, Jorma / Turan, Serap Demircioglu

IMPACT FACTOR 2018: 1.239

CiteScore 2018: 1.22

SCImago Journal Rank (SJR) 2018: 0.507
Source Normalized Impact per Paper (SNIP) 2018: 0.562

See all formats and pricing
More options …
Volume 30, Issue 2


High predictability of impaired glucose tolerance by combining cardiometabolic screening parameters in obese children

Cornelis Jan de Groot
  • Corresponding author
  • Willem-Alexander Children’s Hospital, Leiden University Medical Center, PO box 9600, 2333 ZA, Leiden, The Netherlands, Phone: +31 70 526 2824
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Jeroen van der Grond / Yosine Delgado
  • Willem-Alexander Children’s Hospital, Leiden University Medical Center, Leiden, The Netherlands
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Edmond H.H.M. Rings
  • Willem-Alexander Children’s Hospital, Leiden University Medical Center, Leiden, The Netherlands
  • Sophia Children’s Hospital, Erasmus University Medical Center, Rotterdam, The Netherlands
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Sabine E. Hannema
  • Willem-Alexander Children’s Hospital, Leiden University Medical Center, Leiden, The Netherlands
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Erica L.T. van den Akker
Published Online: 2017-01-11 | DOI: https://doi.org/10.1515/jpem-2016-0289



There is debate on which overweight and obese children should be screened for the presence of impaired glucose tolerance (IGT) by oral glucose tolerance testing (OGTT). The objective of the study was to identify risk factors predictive of the presence of IGT.


In a cohort of overweight children, who underwent OGTT, we determined the association of anthropometric and laboratory parameters with IGT and whether combining parameters improved the sensitivity of screening for IGT.


Out of 145 patients, IGT was present in 11, of whom two had impaired fasting glucose (IFG). Elevated blood pressure (p=0.025) and elevated liver enzymes (p=0.003) were associated with IGT, whereas IFG was not (p=0.067), screening patients with either one of these parameters predicted IGT with a high sensitivity of 1.00, and a number needed to screen of 5.7.


Screening all patients with either IFG, presence of elevated blood pressure and elevated liver enzymes, significantly increases predictability of IGT compared to using IFG alone.

Keywords: glucose abnormalities; impaired fasting glucose; impaired glucose tolerance; liver enzymes; oral glucose tolerance test


  • 1.

    Gupta N, Shah P, Nayyar S, Misra A. Childhood obesity and the metabolic syndrome in developing countries. Indian J Pediatr 2013;80(Suppl 1):S28–37.Google Scholar

  • 2.

    Lobstein T, Frelut ML. Prevalence of overweight among children in Europe. Obes Rev 2003;4:195–200.Google Scholar

  • 3.

    Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999–2010. J Am Med Assoc 2012;307:483–90.Google Scholar

  • 4.

    Schonbeck Y, Talma H, van DP, Bakker B, Buitendijk SE, et al. Increase in prevalence of overweight in Dutch children and adolescents: a comparison of nationwide growth studies in 1980, 1997 and 2009. PLoS One 2011;6:e27608.Google Scholar

  • 5.

    Rotteveel J, Belksma EJ, Renders CM, HiraSing RA, Delemarre-Van de Waal HA. Type 2 diabetes in children in the Netherlands: the need for diagnostic protocols. Eur J Endocrinol 2007;157:175–80.Google Scholar

  • 6.

    Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002;346:802–10.Google Scholar

  • 7.

    Tirosh A, Shai I, Afek A, Dubnov-Raz G, Ayalon N, et al. Adolescent BMI trajectory and risk of diabetes versus coronary disease. N Engl J Med 2011;364:1315–25.Google Scholar

  • 8.

    Standards of medical care in diabetes – 2012. Diabetes Care 2012;35(Suppl 1):S11–63.Google Scholar

  • 9.

    Cali’ AM, Bonadonna RC, Trombetta M, Weiss R, Caprio S. Metabolic abnormalities underlying the different prediabetic phenotypes in obese adolescents. J Clin Endocrinol Metab 2008;93:1767–73.Google Scholar

  • 10.

    Weiss R, Dufour S, Taksali SE, Tamborlane WV, Petersen KF, et al. Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning. Lancet 2003;362:951–7.Google Scholar

  • 11.

    Weiss R, Taksali SE, Tamborlane WV, Burgert TS, Savoye M, et al. Predictors of changes in glucose tolerance status in obese youth. Diabetes Care 2005;28:902–9.Google Scholar

  • 12.

    Franks PW, Hanson RL, Knowler WC, Moffett C, Enos G, et al. Childhood predictors of young-onset type 2 diabetes. Diabetes 2007;56:2964–72.Google Scholar

  • 13.

    Guideline – Evaluation and treatment of obesity in adults and children. CBO; 2010.Google Scholar

  • 14.

    Cambuli VM, Incani M, Pilia S, Congiu T, Cavallo MG, et al. Oral glucose tolerance test in Italian overweight/obese children and adolescents results in a very high prevalence of impaired fasting glycaemia, but not of diabetes. Diabetes Metab Res Rev 2009;25:528–34.Google Scholar

  • 15.

    Conwell LS, Batch JA. Oral glucose tolerance test in children and adolescents: positives and pitfalls. J Paediatr Child Health 2004;40:620–6.Google Scholar

  • 16.

    Kleber M, deSousa G, Papcke S, Wabitsch M, Reinehr T. Impaired glucose tolerance in obese white children and adolescents: three to five year follow-up in untreated patients. Exp Clin Endocrinol Diabetes 2011;119:172–6.Google Scholar

  • 17.

    Love-Osborne K, Butler N, Gao D, Zeitler P. Elevated fasting triglycerides predict impaired glucose tolerance in adolescents at risk for type 2 diabetes. Pediatr Diabetes 2006;7:205–10.Google Scholar

  • 18.

    Tirabanchasak S, Siripunthana S, Supornsilchai V, Wacharasindhu S, Sahakitrungruang T. Insulin dynamics and biochemical markers for predicting impaired glucose tolerance in obese Thai youth. J Pediatr Endocrinol Metab 2015;28:1039–45.Google Scholar

  • 19.

    van der Aa MP, Fazeli FS, Kromwijk LA, de BA, Knibbe CA, et al. How to screen obese children at risk for type 2 diabetes mellitus? Clin Pediatr (Phila) 2014;53:337–42.Google Scholar

  • 20.

    Libman IM, Barinas-Mitchell E, Bartucci A, Robertson R, Arslanian S. Reproducibility of the oral glucose tolerance test in overweight children. J Clin Endocrinol Metab 2008;93:4231–7.Google Scholar

  • 21.

    Maffeis C, Pinelli L, Brambilla P, Banzato C, Valzolgher L, et al. Fasting plasma glucose (FPG) and the risk of impaired glucose tolerance in obese children and adolescents. Obesity (Silver Spring) 2010;18:1437–42.Google Scholar

  • 22.

    Velasquez-Mieyer PA, Cowan PA, Neira CP, Tylavsky F. Assessing the risk of impaired glucose metabolism in overweight adolescents in a clinical setting. J Nutr Health Aging 2008;12:750S–7S.Google Scholar

  • 23.

    Morrison JA, Glueck CJ, Horn PS, Wang P. Childhood predictors of adult type 2 diabetes at 9- and 26-year follow-ups. Arch Pediatr Adolesc Med 2010;164:53–60.Google Scholar

  • 24.

    Lee HS, Park HK, Hwang JS. HbA1c and glucose intolerance in obese children and adolescents. Diabet Med 2012;29:e102–5.Google Scholar

  • 25.

    Tsay J, Pomeranz C, Hassoun A, Zandieh SO, Rutledge J, et al. Screening markers of impaired glucose tolerance in the obese pediatric population. Horm Res Paediatr 2010;73:102–7.Google Scholar

  • 26.

    D’Adamo E, Impicciatore M, Capanna R, Loredana MM, Masuccio FG, et al. Liver steatosis in obese prepubertal children: a possible role of insulin resistance. Obesity (Silver Spring) 2008;16:677–83.Google Scholar

  • 27.

    Schiaffini R, Liccardo D, Alisi A, Benevento D, Cappa M, et al. Early glucose derangement detected by continuous glucose monitoring and progression of liver fibrosis in nonalcoholic fatty liver disease: an independent predictive factor? Horm Res Paediatr 2016;85:29–34.Google Scholar

  • 28.

    Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. Br Med J 2000;320:1240–3.Google Scholar

  • 29.

    Tanner JM. Growth and maturation during adolescence. Nutr Rev 1981;39:43–55.Google Scholar

  • 30.

    Talma H, Schonbeck Y, Bakker B, HiraSing RA, Buuren Sv. Growthcharts 2010: Guide for measuring and weighing children and filling out growth charts. TNO Kwaliteit van leven; 2010.Google Scholar

  • 31.

    The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004;114(2 Suppl 4th Report):555–76.Google Scholar

  • 32.

    Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–9.Google Scholar

  • 33.

    Allard P, Delvin EE, Paradis G, Hanley JA, O’Loughlin J, et al. Distribution of fasting plasma insulin, free fatty acids, and glucose concentrations and of homeostasis model assessment of insulin resistance in a representative sample of Quebec children and adolescents. Clin Chem 2003;49:644–9.Google Scholar

  • 34.

    D’annunzio G, Vanelli M, Pistorio A, Minuto N, Bergamino L, et al. Insulin resistance and secretion indexes in healthy Italian children and adolescents: a multicentre study. Acta Biomed 2009;80:21–8.Google Scholar

  • 35.

    Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499–502.Google Scholar

  • 36.

    Gotto AM Jr, Bierman EL, Connor WE, Ford CH, Frantz ID Jr, et al. Recommendations for treatment of hyperlipidemia in adults. A joint statement of the Nutrition Committee and the Council on Arteriocslerosis. Circulation 1984;69:1065A–90A.Google Scholar

  • 37.

    Bergmeyer HU, Horder M, Rej R. International Federation of Clinical Chemistry (IFCC) Scientific Committee, Analytical Section: approved recommendation (1985) on IFCC methods for the measurement of catalytic concentration of enzymes. Part 3. IFCC method for alanine aminotransferase (L-alanine: 2-oxoglutarate aminotransferase, EC J Clin Chem Clin Biochem 1986;24:481–95.Google Scholar

  • 38.

    Ou HY, Wang CY, Yang YC, Chen MF, Chang CJ. The association between nonalcoholic fatty pancreas disease and diabetes. PLoS One 2013;8:e62561.CrossrefGoogle Scholar

  • 39.

    Saad V, Wicklow B, Wittmeier K, Hay J, MacIntosh A, et al. A clinically relevant method to screen for hepatic steatosis in overweight adolescents: a cross sectional study. BMC Pediatr 2015;15:151.Google Scholar

  • 40.

    Lee JM, Gebremariam A, Wu EL, LaRose J, Gurney JG. Evaluation of nonfasting tests to screen for childhood and adolescent dysglycemia. Diabetes Care 2011;34:2597–602.Google Scholar

  • 41.

    Shah S, Kublaoui BM, Oden JD, White PC. Screening for type 2 diabetes in obese youth. Pediatrics 2009;124:573–9.Google Scholar

  • 42.

    Chan CL, Pyle L, Newnes L, Nadeau KJ, Zeitler PS, et al. Continuous glucose monitoring and its relationship to hemoglobin A1c and oral glucose tolerance testing in obese and prediabetic youth. J Clin Endocrinol Metab 2015;100:902–10.Google Scholar

  • 43.

    Radhakishun NN, van VM, von Rosenstiel IA, Weijer O, Beijnen JH, et al. Increasing thyroid-stimulating hormone is associated with impaired glucose metabolism in euthyroid obese children and adolescents. J Pediatr Endocrinol Metab 2013;26:531–7.Google Scholar

About the article

Received: 2016-07-19

Accepted: 2016-11-21

Published Online: 2017-01-11

Published in Print: 2017-02-01

Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission. Corjan de Groot: Drs. de Groot conceptualized and designed the study, collected and analyzed the data and drafted the initial manuscript. Jeroen van der Grond: Dr. van der Grond provided extensive support in data analysis, edited the initial manuscript and critically reviewed the final manuscript. Yosine Delgado: Ms. Delgado collected the data, was involved in analyzing the data and critically reviewed the final manuscript. Edmond Rings: Prof. dr. Rings supervised the project and critically reviewed the final manuscript. Sabine Hannema: Dr. Hannema had valuable input on the design of the study and analysis of the data and critically reviewed the final version of the manuscript. Erica van den Akker: Dr. van den Akker had valuable input on the design of the study, the analysis of data, editing of the initial manuscript and critically reviewed the final version of the manuscript.

Research funding: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

Citation Information: Journal of Pediatric Endocrinology and Metabolism, Volume 30, Issue 2, Pages 189–196, ISSN (Online) 2191-0251, ISSN (Print) 0334-018X, DOI: https://doi.org/10.1515/jpem-2016-0289.

Export Citation

©2017 Walter de Gruyter GmbH, Berlin/Boston.Get Permission

Comments (0)

Please log in or register to comment.
Log in